Gossamer Bio, Inc. Forecast, price target & analysts
Gossamer Bio, Inc. Target price 2025 - Analyst rating & recommendation
Gossamer Bio, Inc. Classifications & Recommendation:
Gossamer Bio, Inc. Price Target
| Target Price | $9.18 |
| Price | $3.14 |
| Potential |
192.36%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Gossamer Bio, Inc. 2026 .
The average Gossamer Bio, Inc. target price is $9.18.
This is
192.36%
register free of charge
$15.75
401.59%
register free of charge
$6.06
92.99%
register free of charge
|
|
| A rating was issued by 15 analysts: 13 Analysts recommend Gossamer Bio, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Gossamer Bio, Inc. stock has an average upside potential 2026 of
192.36%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 114.70 | 37.92 |
| 66.94% | ||
| EBITDA Margin | -51.52% | -377.71% |
| 633.18% | ||
| Net Margin | -49.29% | -419.92% |
| 752.02% |
10 Analysts have issued a sales forecast Gossamer Bio, Inc. 2025 . The average Gossamer Bio, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Gossamer Bio, Inc. EBITDA forecast 2025. The average Gossamer Bio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Gossamer Bio, Inc. Analysts have issued a net profit forecast 2025. The average Gossamer Bio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.25 | -0.69 |
| 78.81% | 176.00% | |
| P/E | negative | |
| EV/Sales | 19.64 |
10 Analysts have issued a Gossamer Bio, Inc. forecast for earnings per share. The average Gossamer Bio, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Gossamer Bio, Inc....
Current Gossamer Bio, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | May 16 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | May 16 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 11 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Aug 06 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 16 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
May 16 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
